Investing.com cites USD 260.55 target for Welltower stock
Published on 10/26/2026 at 17:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and market value
- Investing.com cited a USD 260.55 consensus target from 22 analysts on October 26, 2026.
- Eighteen of 22 analysts carried Buy ratings in the same October 26, 2026 assessment.
- Welltower stock costs EUR 213.30 at Lang & Schwarz on October 26, 2026 at 5:30 p.m. CET.
Welltower Inc. (US95040Q1040) has a USD 260.55 consensus price target from 22 analysts, according to Investing.com on October 26, 2026. Eighteen of those 22 analysts rated the stock Buy. At Lang & Schwarz, it was trading at EUR 213.30 on October 26, 2026 at 5:30 p.m. CET.
Consensus leaves a measurable gap
The consensus target implies a USD 21.86 difference over the NYSE price of USD 238.69 at 12:32 p.m. EDT on October 26, 2026. That is 9.16 percent above the primary-exchange price, keeping the analyst view as a clear valuation reference rather than a price forecast made by this article.
The latest named target actions were mixed. MarketScreener reported that Barclays cut its target from USD 259.00 to USD 246.00 on October 13, 2026. Wells Fargo had raised its target to USD 268.00 on October 19, 2026, according to the October 26 market report.
What does the price position show?
Welltower's NYSE price of USD 238.69 stood within its USD 174.91 to USD 255.20 52-week range on October 26, 2026. It was 6.47 percent below the high and 36.47 percent above the low. The company's market capitalization was USD 172.0 billion on the same date, while its price-to-earnings ratio was 126.22.
Valuation and scheduled results
Welltower is listed on the NYSE under the ticker WELL and belongs to the S&P 500, according to Welltower. The company operates seniors housing, post-acute care and outpatient medical properties across the United States, Canada and the United Kingdom. Its third-quarter results were scheduled for October 26, 2026, after the NYSE close, according to the October 26 earnings preview.
Comparison with peers
Ventas: 0.50 percent higher on October 26, 2026, price-to-earnings ratio 161.40, market capitalization USD 44.7 billion.
Omega Healthcare Investors: 1.41 percent higher on October 26, 2026, price-to-earnings ratio 16.74, market capitalization USD 14.2 billion.
What matters for the stock
The investor picture combines a USD 260.55 consensus target with a wide spread in valuation multiples across healthcare real estate peers. The next market reaction will depend on how the scheduled results compare with the expectations already reflected in the analyst target range.
At Lang & Schwarz, Welltower stock was trading at EUR 213.30 on October 26, 2026 at 5:30 p.m. CET. The further course of trading is shown by the continuously updated real-time quote of Welltower stock.
Welltower stock facts
- Company: Welltower Inc.
- ISIN: US95040Q1040
- Ticker: WELL
- Primary exchange: NYSE
- Price Lang & Schwarz (as of October 26, 2026, 5:30 p.m. CET): EUR 213.30
- Market capitalization: USD 172.0 billion (as of October 26, 2026)
- 52-week range: USD 174.91-255.20 (as of October 26, 2026)
- Sector / Industry: Real Estate / Healthcare Facilities REIT
- Index membership: S&P 500
Market context: Market report S&P 500.
